Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Bleomycin injections in mice cause skin thickening and hair loss.

Some skin tumors from hair follicles and glands can be linked to genetic syndromes and may be benign or malignant.

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Patients with chronic renal failure on hemodialysis often have skin problems like dry skin, itching, and nail changes.

Hair transplantation for Frontal Fibrosing Alopecia may work if done after the disease is inactive for 2 years and with ongoing treatment after surgery.

Some overweight or obese men with long-term frontal fibrosing alopecia may have abnormal sex hormone levels.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Hair transplantation for Frontal Fibrosing Alopecia may work if the disease is inactive for 2 years and with ongoing treatment to maintain results.

Hepatitis C treatment may cause frontal fibrosing alopecia.

A 3-month stay in space causes skin thinning, disrupts hair growth, and changes muscle-related genes in mice.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

BMS-470539 reduces skin fibrosis and inflammation.

Understanding developmental pathways can improve wound healing treatments.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

New effective scar treatments are urgently needed due to the current options' limited success.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Lowering testosterone speeds up wound healing in male mice.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Hyaluronidase speeds up wound healing and reduces inflammation.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.